Related Experiment Video
Updated: Oct 17, 2025

Spectral Confocal Imaging of Fluorescently tagged Nicotinic Receptors in Knock-in Mice with Chronic Nicotine Administration
Published on: February 10, 2012
Association of Nicotine Use Disorder with Neurexin 3 Gene Polymorphisms
Genetic variations in the Neurexin 3 gene (NRXN3) are linked to nicotine use disorder (NUD) risk in the Turkish population. Specific alleles at rs11624704 and rs1004212 increase the likelihood of developing nicotine addiction.
Area of Science:
- Genetics
- Neuroscience
- Psychiatry
Background:
- Nicotine use disorder (NUD) poses a significant public health challenge.
- Genetic factors are implicated in the susceptibility to NUD.
- The Neurexin 3 gene (NRXN3) has been proposed as a potential candidate gene for NUD.
Purpose of the Study:
- To investigate the association between NRXN3 gene polymorphisms (rs 221473, rs 221497, rs1004212, and rs11624704) and NUD in the Turkish population.
- To identify specific NRXN3 variants that may confer a higher risk for nicotine addiction.
Main Methods:
- A case-control study involving 200 NUD patients and 200 controls from the Turkish population.
- Genotyping of NRXN3 polymorphisms using duplex fluorescence melting curve analysis.
- Assessment of nicotine dependence using the Fagerström Nicotine Dependence Scale (FNDS).
Main Results:
- Individuals with the AC allele at rs11624704 showed an increased risk of NUD.
- Individuals with the AG allele at rs1004212 also exhibited a higher risk of nicotine addiction.
- No significant associations were found for polymorphisms at rs 221473 and rs 221497.
Conclusions:
- This study provides the first evidence linking NRXN3 gene polymorphisms to NUD in the Turkish population.
- The findings suggest that NRXN3 may play a role in the genetic predisposition to nicotine addiction.
- Further research is warranted to elucidate the functional mechanisms underlying this association.
More Related Videos
12:19Live Imaging of Nicotine Induced Calcium Signaling and Neurotransmitter Release Along Ventral Hippocampal Axons
Published on: June 24, 2015
10:48Probing Nicotinic Acetylcholine Receptor Function in Mouse Brain Slices via Laser Flash Photolysis of Photoactivatable Nicotine
Published on: January 25, 2019
Related Concept Videos
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
CNS Depressants: Alcohol and Nicotine
Cholinergic Receptors: Nicotinic
There are two types of nicotinic receptors: neuromuscular (NM/NM/N1) and neuronal (NN/NN/N2). The two families differ based on their location and selectivity to...
Human Genetics
The complex relationship between genetics and psychology is observable through common biological components such...
Single Nucleotide Polymorphisms-SNPs
Drugs Affecting Neurotransmitter Release or Uptake